Nevertheless, the continuous investigation of molecular targets holds the key to successful cancer treatments, and a detailed profiling of HDAC modifications along with their inhibition mechanisms might prove to be a promising approach toward a more effective SGT treatment. Here, HDAC9 is linked to cancer.